Serious complications of COVID-19 vaccines: A mini-review.
Adverse events
COVID-19
Complications
Vaccines
Journal
Metabolism open
ISSN: 2589-9368
Titre abrégé: Metabol Open
Pays: England
ID NLM: 101767753
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
31
08
2021
revised:
28
10
2021
accepted:
28
10
2021
entrez:
8
11
2021
pubmed:
9
11
2021
medline:
9
11
2021
Statut:
ppublish
Résumé
Τhe most promising approach of fighting COVID-19 and restraining the course of this pandemic is indisputably the universal vaccination of the population with safe and effective vaccines. However, besides the common and usually mild side effects of the authorized vaccines, some rare, major adverse reactions are increasingly being reported worldwide during the post marketing surveillance phase of vaccines' circulation, such as anaphylaxis, vaccine-induced thrombotic thrombocytopenia, myopericarditis and Guillain-Barré syndrome. Despite rare cases with complications from COVID-19 vaccines, the net benefit-risk ratio shows a clearly favorable balance towards COVID-19 vaccination for all age and sex groups. Vaccine adverse events should be identified early and monitored closely. As many aspects of these adverse effects remain still obscure for the medical community and the relevant stakeholders, it is also highly important to be promptly reported. Nonetheless, these complications should not constitute a reason to change the vaccine policy and further studies are needed to alleviate concerns and reluctance to COVID-19 vaccinations.
Identifiants
pubmed: 34746732
doi: 10.1016/j.metop.2021.100145
pii: S2589-9368(21)00069-4
pmc: PMC8556676
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100145Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
None to declare.
Références
J Neuroimmunol. 2021 Oct 15;359:577691
pubmed: 34416410
Metabol Open. 2021 Dec;12:100124
pubmed: 34541483
N Engl J Med. 2021 Oct 28;385(18):1680-1689
pubmed: 34379914
MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):46-51
pubmed: 33444297
MMWR Morb Mortal Wkly Rep. 2021 May 07;70(18):680-684
pubmed: 33956784
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Circulation. 2021 Aug 10;144(6):471-484
pubmed: 34281357
Nature. 2021 Aug;596(7873):565-569
pubmed: 34233346
N Engl J Med. 2021 Jun 3;384(22):2124-2130
pubmed: 33835768
World Allergy Organ J. 2020 Oct 30;13(10):100472
pubmed: 33204386
J Neuroimmunol. 2021 Sep 15;358:577606
pubmed: 34182207
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):125-129
pubmed: 33507892
Vaccine. 2020 Mar 23;38(14):3015-3020
pubmed: 32131975
Metabol Open. 2021 Sep;11:100102
pubmed: 34222851
N Engl J Med. 2021 Jun 10;384(23):2254-2256
pubmed: 33861524
Neuroepidemiology. 2011;36(2):123-33
pubmed: 21422765
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1094-1099
pubmed: 34383735
Metabol Open. 2021 Sep;11:100101
pubmed: 34179744
N Engl J Med. 2021 Aug 19;385(8):720-728
pubmed: 34107198
N Engl J Med. 2021 Jun 3;384(22):2092-2101
pubmed: 33835769
Cureus. 2021 Jun 26;13(6):e15935
pubmed: 34336436
Neurol Sci. 2021 Nov;42(11):4401-4402
pubmed: 34346014
Children (Basel). 2021 Jul 18;8(7):
pubmed: 34356586
Cureus. 2021 Feb 18;13(2):e13426
pubmed: 33758714
Clin Neurol Neurosurg. 2021 Sep;208:106839
pubmed: 34325334
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102170
pubmed: 34186348
Lancet. 2021 Jan 9;397(10269):72-74
pubmed: 33306990
Eur J Neurol. 2021 Oct;28(10):3517-3529
pubmed: 33837630
Acta Neurol Belg. 2021 Aug;121(4):1089-1091
pubmed: 34018145
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Lancet Infect Dis. 2021 Aug 16;:
pubmed: 34411532
J Allergy Clin Immunol Pract. 2021 Oct;9(10):3546-3567
pubmed: 34153517
World Allergy Organ J. 2011 Feb;4(2):13-37
pubmed: 23268454